tykhr
sign in
free sign up
Adaptimmune Therapeutics Plc
Biotechnology
Healthcare
ADAP
164 M shares
NASDAQ US
traded
17 May 2023
listed
yes
open
1.32
52 week high
3.18
high
1.38
52 week low
1.32
low
1.28
growth
-11.84 %
previous Close
1.39
P/E ratio
market cap
235 M
div yield
0
usd
Mar 2023
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
265.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top